BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 20932697)

  • 1. Moyamoya disease in children.
    Takanashi J
    Brain Dev; 2011 Mar; 33(3):229-34. PubMed ID: 20932697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal high signal intensity (ivy sign) on fluid-attenuated inversion-recovery (FLAIR) MR images in moyamoya disease.
    Fujiwara H; Momoshima S; Kuribayashi S
    Eur J Radiol; 2005 Aug; 55(2):224-30. PubMed ID: 16036151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiological consideration of medullary streaks on FLAIR imaging in pediatric moyamoya disease.
    Suzuki H; Mikami T; Kuribara T; Yoshifuji K; Komatsu K; Akiyama Y; Ohnishi H; Houkin K; Mikuni N
    J Neurosurg Pediatr; 2017 May; 19(5):560-566. PubMed ID: 28291429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Moya' than meets the eye: neurofibromatosis type 1 associated with Moyamoya syndrome.
    Tan RM; Chng SM; Seow WT; Wong J; Lim CC
    Singapore Med J; 2008 Apr; 49(4):e107-9. PubMed ID: 18418511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Ivy sign" in childhood moyamoya disease: depiction on FLAIR and contrast-enhanced T1-weighted MR images.
    Yoon HK; Shin HJ; Chang YW
    Radiology; 2002 May; 223(2):384-9. PubMed ID: 11997541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease.
    Huang AP; Liu HM; Lai DM; Yang CC; Tsai YH; Wang KC; Yang SH; Kuo MF; Tu YK
    Cerebrovasc Dis; 2009; 28(3):247-57. PubMed ID: 19602876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unstable moyamoya disease: clinical features and impact on perioperative ischemic complications.
    Funaki T; Takahashi JC; Takagi Y; Kikuchi T; Yoshida K; Mitsuhara T; Kataoka H; Okada T; Fushimi Y; Miyamoto S
    J Neurosurg; 2015 Feb; 122(2):400-7. PubMed ID: 25423271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
    Hayashi T; Shirane R; Fujimura M; Tominaga T
    J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with moyamoya disease presenting with movement disorder.
    Pandey P; Bell-Stephens T; Steinberg GK
    J Neurosurg Pediatr; 2010 Dec; 6(6):559-66. PubMed ID: 21121731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral hemodynamics and oxygen metabolism in patients with moyamoya syndrome associated with atherosclerotic steno-occlusive arterial lesions.
    Kato H; Shimosegawa E; Oku N; Kimura Y; Kajimoto K; Tanaka M; Hori M; Kitagawa K; Hatazawa J
    Cerebrovasc Dis; 2008; 26(1):9-15. PubMed ID: 18511866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Ivy Sign on Fluid Attenuated Inversion Recovery Images Related to Single-Photon Emission Computed Tomography Cerebral Blood Flow in Moyamoya Disease: A Case Report.
    Matano F; Murai Y; Kubota A; Mizunari T; Kobayashi S; Morita A
    Turk Neurosurg; 2019; 29(4):598-602. PubMed ID: 28191623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usefulness and limitation of MR imaging and MR angiography in diagnosis of juvenile moyamoya disease].
    Aoki T; Matsuzawa H; Houkin K; Kamiyama H; Abe H; Miyasaka K; Saito H
    No Shinkei Geka; 1993 Apr; 21(4):305-11. PubMed ID: 8474584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Moyamoya disease].
    Tokunaga K; Date I
    Brain Nerve; 2008 Jan; 60(1):37-42. PubMed ID: 18232331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Focal time-to-peak changes on perfusion MRI in children with Moyamoya disease: correlation with conventional angiography.
    Choi HS; Kim DS; Shim KW; Kim J; Kim ES; Lee SK
    Acta Radiol; 2011 Jul; 52(6):675-9. PubMed ID: 21525108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moyamoya disease--magnetic resonance imaging and magnetic resonance angiographic features.
    Gupta R; Kumari R; Gupta N; Prakash A; Chowdhury V
    J Indian Med Assoc; 2006 Apr; 104(4):198-9. PubMed ID: 16910328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical symptoms and diagnostic imaging in moyamoya disease].
    Christopoulos G; Ziegler V; Coblenz G; Wedell E; Griewing B; Schmitt R
    Rontgenpraxis; 2003; 55(1):39-45. PubMed ID: 12650037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse and uncontrolled vascular smooth muscle cell proliferation in rapidly progressing pediatric moyamoya disease.
    Reid AJ; Bhattacharjee MB; Regalado ES; Milewicz AL; El-Hakam LM; Dauser RC; Milewicz DM
    J Neurosurg Pediatr; 2010 Sep; 6(3):244-9. PubMed ID: 20809708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of brain magnetic resonance images at symptom onset in children with moyamoya disease.
    Jung MY; Kim YO; Yoon W; Joo SP; Woo YJ
    Brain Dev; 2015 Mar; 37(3):299-306. PubMed ID: 25022806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.